Gotenba, Japan

Yasuka Kinoshita

This inventor holds 1 USPTO granted patent. Top assignee: Chugai Seiyaku Kabushiki Kaisha. Active years: 2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yasuka Kinoshita. Retrieved from https://idiyas.com/inventor/yasuka-kinoshita

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2012

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Yasuka Kinoshita: Innovator in Antibody Development

Introduction

Yasuka Kinoshita is a prominent inventor based in Gotenba, Japan. She has made significant contributions to the field of biotechnology, particularly in the development of humanized antibodies. Her work focuses on therapeutic agents for hematological disorders, showcasing her commitment to advancing medical science.

Latest Patents

Kinoshita holds a patent for a "Humanized anti-CD47 antibody." This invention relates to humanized antibodies that bind to CD47, including diabodies characterized by a disulfide bond between diabody-forming fragments. The patent also covers genes encoding these antibodies, vectors containing said genes, host cells with these vectors, and processes for preparing antibodies through the culturing of host cells.

Career Highlights

Throughout her career, Yasuka Kinoshita has been associated with Chugai Seiyaku Kabushiki Kaisha, a leading pharmaceutical company. Her innovative work has led to advancements in antibody therapies, contributing to the treatment of various hematological conditions.

Collaborations

Kinoshita has collaborated with notable colleagues, including Yasufumi Kikuchi and Shinsuke Uno. These partnerships have fostered a collaborative environment that enhances research and development efforts in the field of biotechnology.

Conclusion

Yasuka Kinoshita's contributions to the development of humanized antibodies exemplify her dedication to innovation in medical science. Her work continues to impact the field positively, paving the way for new therapeutic solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…